2.__Rulemaking.__The Office of Substance Abuse may adopt rules to carry out the purposes of this chapter. Rules adopted pursuant to this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter 2-A.

Sec. 6. 32 MRSA §13702, sub-§25-B is enacted to read:

25-B.__Targeted methamphetamine precursor.__"Targeted methamphetamine precursor" means:

A.__Any product containing any amount of ephedrine, pseudoephedrine or phenylpropanolamine or their salts, isomers or salts of isomers, either alone or in combination with other ingredients, in dry or solid nonliquid form; and

B.__Any product containing any amount of ephedrine, pseudoephedrine or phenylpropanolamine or their salts, isomers or salts of isomers, either alone or in combination with other ingredients, in liquid, liquid-filled capsule or glycerin matrix form if such products are designated as targeted methamphetamine precursors by rule adopted by the Department of Public Safety pursuant to section 13795, subsection 5, paragraph A.

Sec. 7. 32 MRSA §13795, as amended by PL 1997, c. 437, §46, is further amended to read:

§13795. Photographic proof of identification; discretion to sell

or dispense; immunity

1. Photographic proof of identification. As a precondition to filling any prescription or, dispensing any drug, or selling any targeted methamphetamine precursor, a pharmacist or person acting at the direction of a pharmacist may demand, inspect and record proof of identification, including valid photographic identification, from any patient presenting a prescription or any person acting on behalf of the patient or person purchasing a targeted methamphetamine precursor. Valid photographic identification includes but is not limited to the following:

A. A valid Maine motor vehicle operator's license;